Investor's Business Daily on MSN10d
Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week
Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.
MyVeronaNJ6d
Why Pool Rates Are Likely To Rise
Verona’s municipal spending is paid for by all Verona residents. But the expenses of the Verona Community Pool must be ...
pharmaphorum2y
Verona builds case for COPD drug ensifentrine as filing nears
Verona Pharma is looking odds on for a regulatory ... The Anglo-US company reported the results of the ENHANCE-1 study earlier today, with the first-in-class phosphodiesterase 3 and 4 inhibitor ...
pharmaphorum8d
Verona cues up filings for COPD drug after it aces phase 3 test
UK-based Verona Pharma has scored a key win in a phase ... chronic maintenance therapy for people with COPD in the ENHANCE-2 study, cutting the rate of moderate to severe exacerbations – sudden ...
The Oneida Daily Dispatch on MSN7d
VVS enrollment discussions begin
The Vernon-Verona-Sherrill School District has invited members of the VVS community to address current and future enrollment ...
Nasdaq1mon
Roth MKM Initiates Coverage of Verona Pharma plc - Depositary Receipt () (VRNA) with Buy Recommendation
Verona Pharma Background Information (This description ... Ensifentrine is being evaluated in a pilot clinical study in patients hospitalized with COVID-19 and has potential applications in ...